Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6d4d7321e22e3b85d537f2b3f9b1f9b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5123 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2008-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_366118e3a1cb844affbba90c27c9b97d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56b72bbde4a73759897112df964ac363 |
publicationDate |
2010-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2197454-A1 |
titleOfInvention |
Pharmaceutical compositions for administering oligonucleotides |
abstract |
The invention relates to pharmaceutical compositions useful for administering an oligonucleotide to an animal in need thereof. The pharmaceutical compositions include nano-particles or micro-particles of (i) a protonated oligonucleotide and (ii) a pharmaceutically acceptable organic base or include nano-particle or micro-particles of (i) an oligonucleotide and (ii) a divalent metal ion. |
priorityDate |
2007-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |